Safety and efficacy of intra-arterial lidocaine administration for pain control in uterine artery embolization for cesarean scar pregnancy.

IF 1.4 Q4 CLINICAL NEUROLOGY
Pain management Pub Date : 2025-06-01 Epub Date: 2025-05-26 DOI:10.1080/17581869.2025.2511464
Tianhong Cai, Rong Zhang, Kai Chen, Ting Deng, Tenghui Zhan
{"title":"Safety and efficacy of intra-arterial lidocaine administration for pain control in uterine artery embolization for cesarean scar pregnancy.","authors":"Tianhong Cai, Rong Zhang, Kai Chen, Ting Deng, Tenghui Zhan","doi":"10.1080/17581869.2025.2511464","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Uterine artery embolization (UAE) for cesarean scar pregnancy (CSP) can cause significant pain.</p><p><strong>Objectives: </strong>To evaluate safety and efficacy of intra-arterial lidocaine during UAE for CSP.</p><p><strong>Methods: </strong>Retrospective study of 255 CSP patients: Control Group (184) without lidocaine; Study Group I (39) with unilateral lidocaine; Study Group II (32) with bilateral lidocaine. Outcomes included VAS pain scores and morphine usage.</p><p><strong>Results: </strong>Early postoperative VAS scores (0-2 hours) were significantly lower in study groups (<i>p</i> < 0.001). No differences in later VAS scores (4-24 hours), maximal VAS scores, morphine dosage, or safety indicators.</p><p><strong>Conclusion: </strong>Intra-arterial lidocaine during UAE for CSP provides effective analgesia immediately post-procedure but only for the first 2-4 hours, without reducing overall opioid requirements.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":" ","pages":"325-332"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140453/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2025.2511464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Uterine artery embolization (UAE) for cesarean scar pregnancy (CSP) can cause significant pain.

Objectives: To evaluate safety and efficacy of intra-arterial lidocaine during UAE for CSP.

Methods: Retrospective study of 255 CSP patients: Control Group (184) without lidocaine; Study Group I (39) with unilateral lidocaine; Study Group II (32) with bilateral lidocaine. Outcomes included VAS pain scores and morphine usage.

Results: Early postoperative VAS scores (0-2 hours) were significantly lower in study groups (p < 0.001). No differences in later VAS scores (4-24 hours), maximal VAS scores, morphine dosage, or safety indicators.

Conclusion: Intra-arterial lidocaine during UAE for CSP provides effective analgesia immediately post-procedure but only for the first 2-4 hours, without reducing overall opioid requirements.

剖宫产瘢痕妊娠子宫动脉栓塞术中动脉内利多卡因镇痛的安全性和有效性。
背景:子宫动脉栓塞术治疗剖宫产瘢痕妊娠(CSP)可引起明显的疼痛。目的:评价利多卡因动脉灌注治疗CSP的安全性和有效性。方法:对255例CSP患者进行回顾性研究:对照组(184例)不使用利多卡因;第一组(39人)单侧使用利多卡因;第二组(32人)双侧利多卡因组。结果包括VAS疼痛评分和吗啡使用情况。结果:实验组术后早期VAS评分(0-2小时)显著降低(p结论:CSP UAE期间动脉内注射利多卡因可在术后立即提供有效镇痛,但仅在前2-4小时内有效,未减少总体阿片类药物需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pain management
Pain management CLINICAL NEUROLOGY-
CiteScore
2.90
自引率
5.90%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信